Does the Troponin I release pattern predict cardiac events in cancer patients undergoing high-dose chemotherapy?
Troponin I release patterns after high-dose chemotherapy can identify patients at varying risks for cardiac events over 3 years, guiding tailored monitoring and preventive care.
TnI release pattern after high-dose chemotherapy identifies patients at different risks of cardiac events in the 3 years thereafter. This stratification allows us to differentiate the monitoring program and to plan, in selected patients, preventive strategies aimed at improving clinical outcome.
Cardinale et al. (2004) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: